-
Something wrong with this record ?
Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant
J. Ballekova, M. Soltesova-Prnova, M. Majekova, M. Stefek
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Aldehyde Reductase antagonists & inhibitors metabolism MeSH
- Anti-Inflammatory Agents chemistry pharmacology MeSH
- Indoles chemistry pharmacology MeSH
- Enzyme Inhibitors metabolism pharmacology MeSH
- Rats MeSH
- Humans MeSH
- NADP metabolism MeSH
- Naphthalenes chemistry pharmacology MeSH
- Rats, Wistar MeSH
- Molecular Docking Simulation methods MeSH
- Binding Sites physiology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The aim of this study was to investigate aldose reductase inhibitory action of setipiprant as a potential additional mechanism contributing to its anti-inflammatory action. Aldose reductase activity was determined by spectrophotometric measuring of NADPH consumption. Setipiprant was found to inhibit aldose reductase/NADPH-mediated reduction of 4-hydroxynonenal, 4-hydroxynonenal glutathione and prostaglandin H2 substrates, all relevant to the process of inflammation. Molecular modeling simulations into the aldose reductase inhibitor binding site revealed an interaction pattern of setipiprant. Considering multifactorial etiology of inflammatory pathologies, it is suggested that, in addition to the antagonizing prostaglandin D2 receptor, inhibition of aldose reductase may contribute to the reported anti-inflammatory action of setipiprant.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18021067
- 003
- CZ-PrNML
- 005
- 20180621135909.0
- 007
- ta
- 008
- 180611s2017 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933516 $2 doi
- 035 __
- $a (PubMed)28406694
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Ballekova, J $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 245 10
- $a Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant / $c J. Ballekova, M. Soltesova-Prnova, M. Majekova, M. Stefek
- 520 9_
- $a The aim of this study was to investigate aldose reductase inhibitory action of setipiprant as a potential additional mechanism contributing to its anti-inflammatory action. Aldose reductase activity was determined by spectrophotometric measuring of NADPH consumption. Setipiprant was found to inhibit aldose reductase/NADPH-mediated reduction of 4-hydroxynonenal, 4-hydroxynonenal glutathione and prostaglandin H2 substrates, all relevant to the process of inflammation. Molecular modeling simulations into the aldose reductase inhibitor binding site revealed an interaction pattern of setipiprant. Considering multifactorial etiology of inflammatory pathologies, it is suggested that, in addition to the antagonizing prostaglandin D2 receptor, inhibition of aldose reductase may contribute to the reported anti-inflammatory action of setipiprant.
- 650 _2
- $a aldehydreduktasa $x antagonisté a inhibitory $x metabolismus $7 D000449
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika $x chemie $x farmakologie $7 D000893
- 650 _2
- $a vazebná místa $x fyziologie $7 D001665
- 650 _2
- $a inhibitory enzymů $x metabolismus $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a indoly $x chemie $x farmakologie $7 D007211
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a simulace molekulového dockingu $x metody $7 D062105
- 650 _2
- $a NADP $x metabolismus $7 D009249
- 650 _2
- $a naftaleny $x chemie $x farmakologie $7 D009281
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Soltesova-Prnova, M. $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Májeková, Magdaléna $7 xx0156565 $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Štefek, Milan $7 xx0246327 $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 4 (2017), s. 687-693
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28406694 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20180611 $b ABA008
- 991 __
- $a 20180619130018 $b ABA008
- 999 __
- $a ok $b bmc $g 1311781 $s 1017939
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 66 $c 4 $d 687-693 $e 20170412 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20180611
